Burning Rock Biotech (BNR) vs MDxHealth SA (MDXH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Burning Rock Biotech (BNR) has outperformed MDxHealth SA (MDXH) over the past year, gaining 70.8% versus a loss of 86.5%. Burning Rock Biotech is the larger company by market cap ($163.4 million vs $56.3 million), about 2.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BNR | MDXH |
|---|---|---|
| Share price | $15.49 | $0.5897 |
| Market cap | $163.36M | $56.27M |
| 1-day change | +3.27% | +1.58% |
| YTD return | -24.57% | -83.48% |
| 1-year return | +70.79% | -86.47% |
| 5-year return | -89.42% | — |
| EPS (TTM) | $-0.80 | $-0.70 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $41.72 | $5.33 |
| 52-week low | $6.79 | $0.40 |
| Distance from 52-week high | -62.87% | -88.94% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +205.24% |
| Average volume | 28.59K | 5.69M |
| Shares outstanding | 8.81M | 95.42M |
| Employees | 667 | 364 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Burning Rock Biotech is about 2.9 times larger than MDxHealth SA by market value ($163.36M vs $56.27M).
- BNR has outperformed MDXH by 157.3 percentage points over the past year.
About Burning Rock Biotech
BNR stock →Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services.
Health Care · Medical Specialities · 667 employees
About MDxHealth SA
MDXH stock →MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.
Health Care · Medical Specialities · 364 employees
BNR vs MDXH FAQ
Which is bigger, Burning Rock Biotech or MDxHealth SA?
Burning Rock Biotech (BNR) is larger, with a market capitalization of $163.36M compared with $56.27M for MDxHealth SA (MDXH).
Which stock has performed better over the past year, BNR or MDXH?
BNR returned +70.79% over the past 12 months, compared with -86.47% for MDXH (price return, excluding dividends). Past performance does not predict future results.
Are Burning Rock Biotech and MDxHealth SA in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.